Interaction of allopurinol and non-steroidal anti-inflammatory drugs on the carrageenan-induced rat paw edema

Saudi Medical Journal

Volumn 24, Issue 9, 2003, Pages 936-940

  Al Arfaj, Abdurhman S ^a,d   Mustafa, Ali A ^b   Alballa, Suliman R ^a   Tuwaijri, Ali S ^a   Al Dalaan, Abdullah N ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d NONE   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CARRAGEENAN; DICLOFENAC; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; TENOXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; NONHUMAN; PAW EDEMA; PLETHYSMOGRAPHY; RAT; SAUDI ARABIA;

ALLOPURINOL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EDEMA; FREE RADICAL SCAVENGERS; HINDLIMB; INDOMETHACIN; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 0141892063     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Johnson RJ, Lovett D, Lehrer RI, Couse WG, Klebanoff SJ. Role of oxidants and proteases in glomerular injury. Kidney Int 1994; 45: 352-359.
2. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-326.
3. Munver R, Delvecchio FC, Kuo RL, Brown SA, Zhong P, Preminger GM. In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system: The renoprotective action of Allopurinol. J Urol 2002; 167: 327-334.
4. Murashima YL, Kasamo K, Suzuki J. Anti-epileptic effects of Allopurinol on EL mice are associated with changes in SOD Isoenzyme activities. Epilepsy Res 1998; 32: 254-265.
5. Vina J, Gimeno A, Sastre J, Desco C, Asensi M, Pallardo FV, et al. Mechanism of free radical production in exhaustive exercise in humans and rats: role of xanthine oxidase and protection by allopurinol. IUBMB Life 2000; 4: 539-544.
6. Icho T, Kojima S, Hayashi M, Kajiwara Y, Kitabatake K. Kubota K. Suppresion of ischemia-reperfusion injury in murine models by neopterins. Toxicol Appl Pharmacol 1995; 130: 27-31.
7. Schlegel SI. General characteristics of non-steroidal anti-inflammatory drugs. In: Paulus HE, Frust DE, Dromogool S, editors. Drugs for Rheumatic Diseases. New York (NY), Churchill Livingstone; 1987. p. 203.
8. Inoue K, Fujisawa H, Motonaga A, Inoue Y, Kyoi T, Ueda F et al. Anti-inflammatory effect of etodolac: comparison with non-steroidal anti-inflammatory drugs. Biol Pharm Bull 1994; 17: 1577-1583.
9. Bekemeir H, Hirschelmann R. On steroid-saving drug combinations in carrageenan paw edema and adjuvant arthritis. Arzneimittelforschung 1986; 36: 1521-1524.
10. Nascimento JW, Santos LH, Nothenberg MS, Coelho MM, Oga S. Anti-inflammatory activity and gastric lesions induced by zinc-tenoxicam. Pharmacology 2003; 68: 64-69.
11. Paget GE, Barnes JM. Evaluation of drug activities in Pharmacometrics. Laurence and Bacharach, editors. Vol. 1. New York (NY): Academic Press; 1964. p. 31-50.
12. Barnes JM, Paget GE. Mechanisms of toxic action. Prog Med Chem 1965; 4:18-38.
13. Gupta SK, Bansal P, Bhardwaj RK, Jaiswal J, Velpondian T. Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: Pharmacokinetic parameters after topical application. Skin Pharmacol Appl Skin Physiol 2002; 15: 105-111.
14. Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther 1999; 288: 1288-1297.
15. Cabre F, Fernandez MF, Calvo L, Ferrer X, Garcia ML, Mauleon D. Analgesic, anti-inflammatory, and antipyretic effects of S (+)-ketoprofen in vivo. J Clin Pharmacol 1998; 38 (Suppl 12): 3S-10S.
16. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A et al. Pharmacological analysis of cyclo-oxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998; 95: 13313-13318.
17. Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol 1971; 231: 235-237.
18. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-235.
19. Williams TJ. Prostaglandin E2, Prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol 1979; 65: 517-524.
20. Ferreira SH, Nakamura M, de Abreu Castro MS. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins 1978; 16: 31-37.
21. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Rev Immunol 1984; 2: 335-357.
22. Movat HZ. The role of histamine and other mediators in microvascular changes in acute inflammation. Can J Physiol Pharmacol 1987; 65: 451-457.
23. Yossif AM, Ibrahim TM, Salem HA, Gamil NN, El-Sayed LM. Effect of high lipid diet and allopurinol on the development of experimentally induced arthritis in rats. Pharmacology 1995; 51: 160-164.
24. Augustin AJ, Spitznas M, Sekundo W, Koch F, Lutz J, Meller D et at. Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: A biochemical and morphological study. Br J Ophthalmol 1996; 80: 451-457.
25. Zahavi I, Fisher S, Marcus H, Heckelman B, Kiro A, Dinari G. Oxygen radical scavengers are protective against indomethacin-induced intestinal ulceration in the rat. J Pediatr Gastroenterol Nutr 1995; 21: 154-157.
26. Kimura K. Mechanism of active oxygen species reduction by non-steroidal anti-inflammatory drugs. Int J Biochem Cell Biol 1997; 29: 437-446.
27. Shacter E, Lopez RL, Pati S. Inhibition of the myeloperoxidase-H202-Cl-system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs. Biochem Pharmacol 1991; 41: 975-984.
28. Mustafa AA, Alballa SR, Al-Twaijri AS, Al-Dalaan A. Calcium channel blockers enhances the inhibitory action of non-steroidal anti-inflammatory drugs on the luminol-dependent chemiluminescence: differential effects of tenoxicam. Saudi Med J 1993; 14: 340-346.
29. Hascelik G, Sener B, Hascelik Z. Effect of some anti-inflammatory drugs on human neutrophils chemotaxis. J Int Med Res 1994; 22: 100-106.
30. Parij N, Nagy AM, Nere J. Linear and non-linear competition plots in the deoxyribose assays for determination of rate constants for reaction of non-steroidal anti-inflammatory drugs with hydroxyl radicals. Free Radic Res 1995; 23: 571-579.
31. Nascimento AL, Escobar JA, Cilento G. The peroxidative metabolism of tenoxicam produces excited species. Photochem Photobiol 1993; 57: 362-366.
32. Ichihara S, Tomisawa H, Fukazawa H, Tateishi M, Joly R, Heintz R. Oxidation of tenoxicam by leukocyte peroxidases and H202 produces novel products. Drug Metab Dispos 1989; 17: 463-468.
33. Nagamatsu T, Pippin J, Schreiner GF, Lefkowith JB. Paradoxical exacerbation of leukocyte-mediated glomerulonephritis with cyclo-oxygenase inhibition. Am J Physiol 1992; 263: 228-236.